Next 10 |
home / stock / rkly / rkly articles
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds invest...
NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited (...
NEW YORK, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds invest...
If you suffered losses exceeding $25,000 investing in SC Health Corporation ("SC Health") (NYSE:SCPE, NYSE:SCPE, NYSE:SCPE) and Rockley Photonics ...
If you suffered losses exceeding $25,000 investing in SC Health Corporation ("SC Health") (NYSE:SCPE, NYSE:SCPE, NYSE:SCPE) and Rockley Photonics ...
If you suffered losses exceeding $25,000 investing in SC Health Corporation ("SC Health") (NYSE:SCPE, NYSE:SCPE, NYSE:SCPE) and Rockley Photonics ...
NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited (...
If you suffered losses exceeding $25,000 investing in SC Health Corporation ("SC Health") (NYSE:SCPE, NYSE:SCPE, NYSE:SCPE) and Rockley Photonics ...
NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rockley Photonics Holdings Limited (...
News, Short Squeeze, Breakout and More Instantly...
Rockley Photonics Holdings Limited Company Name:
RKLY Stock Symbol:
NYSE Market:
Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarkers, today announced that it received 12.9 million pounds sterling ($15...
Rickman to serve as executive chair; Becker promoted to interim chief financial officer Rockley Photonics Holdings Limited (NYSE: RKLY), a global medical technology company focused on delivering leading edge silicon photonics-based biosensing solutions by targeting a portfolio of biomarke...